원격의료 및 원격진료 시장 평가 : 구성요소별, 제공 형태별, 용도별, 최종사용자별, 지역별, 기회, 예측(2017-2031년)

Global telehealth and telemedicine market is projected to witness a CAGR of 15.47% during the forecast period 2024-2031, growing from USD 109.61 billion in 2023 to USD 346.44 billion in 2031F. The market's growth is supported by the rise in the number of chronic diseases, expansion of the healthcare sector, digitization of healthcare, growing awareness about the various advantages of telehealth and telemedicine technologies and increasing government efforts.

The rise in government efforts to bolster product utilization is one of the crucial global telehealth and telemedicine market trends. In November 2023, the national railway company of France announced that it would deploy telemedicine services by 2028 across 300 train stations. The selected stations are in concerted development and priority intervention zones that do not have sufficient healthcare offerings. Such investments are expected to propel the market demand and positively influence the expansion of the market in the coming years.

The adoption of telehealth and telemedicine is also anticipated to increase owing to the ability of the technologies to reduce greenhouse gas emissions associated with cancer care. According to a study published in JAMA Oncology in June 2024, a substantial reduction of emissions was witnessed with decentralized cancer care. In the cohort study that included 123,890 patients seen over 1.6 million visit days, the telemedicine care model reduced per-visit day emissions by 81.3% compared to the in-person care model. In the national counterfactual model, which compared decentralized care (local site care as well as telemedicine when possible) and usual care, a reduction of 33.1% in emissions was witnessed. The cohort study concluded that telehealth has the potential to reduce the greenhouse gas emissions generated by cancer care substantially.

Rising Collaborations to Drive the Global Telehealth and Telemedicine Market

The rise in collaborations between various healthcare companies to enhance access to different healthcare facilities in order to improve patient outcomes is expected to support the growth of the market. For instance, in June 2024, Infosys Technologies Private Limited announced partnerships with NIHON CHOUZAI Co., Ltd. and developed a mobile application for NiCOMS, allowing patients to receive medication guidance from pharmacists remotely. With this collaboration, the companies aim to enhance medical services and boost access to high-quality pharmaceutical interventions in Japan. Such developments are anticipated to enhance patient comfort by allowing patients to connect with healthcare professionals and conveniently receive medication and disease management instructions.

Rising Awareness About Advantages Associated with Telehealth and Telemedicine

The increasing awareness about the different advantages associated with the utilization of telehealth and telemedicine products and services is expected to provide lucrative growth opportunities to the market. The utilization of telehealth and telemedicine aids in providing individuals with mobility limitations access to healthcare. Meanwhile, in the case of chronic condition management, telemedicine allows the patient to connect with the doctor or other healthcare professional and aids in forming long term relationships and also get counseling and mental health assessment in case of requirement in a seamless manner.

The time and cost efficiency offered by these technologies are also bolstering their usage in different regions across the globe. According to a study published in JAMA Network in January 2023, telehealth was associated with savings in travel costs and patient time and can aid in the economic burden associated with treatments. The study included 11,688 patients with 25,496 telehealth visits and showcased that telehealth accounted for an estimated savings of USD 467,247 in lost income due to visit time and USD 11,70,160 in lost income due to driving time.

North America Accounts for a Significant Share in Global Telehealth and Telemedicine Market Share

The market growth in the region is aided by the rising prevalence of different chronic conditions, the expanding healthcare sector, and increasing investments in healthcare IT. According to the American Cancer Society, in 2024, 611,720 cancer-related deaths and 2,001,140 new cases are estimated to occur in the United States. This increase bolsters the utilization of telehealth and telemedicine technologies as they aid the caretakers of patients with advanced cancer in providing quality care to their patients by reducing the burden associated with regular hospital visits. They also aid patients in reducing various indirect costs associated with regular doctor visits, including travel expenses and loss of income due to taking time off work to accommodate medical visits and travel. Due to the advantages of telehealth and telemedicine and the increasing acceptance of remote consultation, the market is witnessing significant growth in North America in the coming years.

Software Segment Expected to Witness Significant Growth

The software segment is expected to witness significant growth in the coming years owing to the various advantages associated with their usage, including safety, convenience, and cost efficiency. Software helps effectively manage chronic diseases, monitor different health conditions, and ensure adherence to medication is practiced. Additionally, the segment's growth is also supported by the rising investments by various companies towards upgrading their software to enhance the quality of care provided to patients, propelling the global telehealth and telemedicine market. In June 2024, telehealth company TytoCare Ltd. announced that it was releasing an update for its Home Smart Clinic software to allow patients access to urgent, primary, and specialty care and make the telehealth experience seamless. The update will also increase the number of healthcare providers patients can connect with, allow patients to record vital data before the visit, and provide a link for every appointment, which will be rolled out to the patients and providers in the coming months.

Future Market Scenario (2024-2031F)

According to the global telehealth and telemedicine market analysis, the requirement for telehealth and telemedicine is expected to increase significantly over the forecast period owing to their ability to streamline the workflow of clinics and hospitals, which is becoming essential as the population expands and the prevalence of chronic diseases increases. These technologies often emphasize high-value tasks and reduce the burden associated with patient check-ins while providing coverage to individuals in rural locations with limited treatment and consultation options.

A rise in research and development activities will also support market growth. For instance, an interventional study, which is expected to conclude in October 2024, is being conducted to evaluate how telehealth exercises aid in enhancing cardiovascular health in lymphoma survivors. Meanwhile, an interventional study is also being conducted to evaluate whether telemedicine follow-ups for patients with leg ulcers and diabetes-related foot ulcers are a viable alternative to traditional follow-ups. The study is expected to conclude in December 2024.

Key Players Landscape and Outlook

The growth of the market is boosted by the increasing collaborations between the key market players and insurance benefits and assistance service companies. For instance, in June 2024, International Medical Group, Inc. and Teladoc Health, Inc. announced the expansion of their partnership. This partnership will expand the International Medical Group's offerings of telehealth services with the utilization of Teladoc's All360Health, an easy-to-use platform available for prescription and telehealth services. With this platform travelers can connect with healthcare experts across the globe via online video and phone consultations. Such partnerships are expected to aid the market players in expanding their customer base and boost the global telehealth and telemedicine market size.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Telehealth and Telemedicine Market Outlook, 2017-2031F

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. By Component
  • 4.2.1. Software
    • 4.2.1.1. Integrated Software
    • 4.2.1.2. Standalone Software
  • 4.2.2. Hardware
    • 4.2.2.1. Monitors
    • 4.2.2.2. Medical Peripheral Devices
      • 4.2.2.2.1. Blood Pressure Meters
      • 4.2.2.2.2. Blood Glucose Meters
      • 4.2.2.2.3. Peak Flow Meters
      • 4.2.2.2.4. ECG Monitors
      • 4.2.2.2.5. Pulse Oximeters
      • 4.2.2.2.6. Weighing Scales
      • 4.2.2.2.7. Others
  • 4.2.3. Services
• 4.3. By Mode of Delivery
  • 4.3.1. On-premise
  • 4.3.2. Cloud-based
• 4.4. By Application
  • 4.4.1. Teleconsultation
  • 4.4.2. Remote Patient Monitoring
  • 4.4.3. Telepathology
  • 4.4.4. Telepsychiatry
  • 4.4.5. Teledermatology
  • 4.4.6. Others
• 4.5. By End-user
  • 4.5.1. Payers
    • 4.5.1.1. Private
    • 4.5.1.2. Public
  • 4.5.2. Providers
    • 4.5.2.1. Hospitals and Clinics
    • 4.5.2.2. Assisted Living Centers and Long-Term Care Centers
  • 4.5.3. Patients
• 4.6. By Region
  • 4.6.1. North America
  • 4.6.2. South America
  • 4.6.3. Europe
  • 4.6.4. Asia-Pacific
  • 4.6.5. Middle East and Africa
• 4.7. By Company Market Share (%), 2023

5. Global Telehealth and Telemedicine Market Outlook, By Region, 2017-2031F

• 5.1. North America*
  • 5.1.1. Market Size & Forecast
    • 5.1.1.1. By Value
  • 5.1.2. By Component
    • 5.1.2.1. Software
      • 5.1.2.1.1. Integrated Software
      • 5.1.2.1.2. Standalone Software
    • 5.1.2.2. Hardware
      • 5.1.2.2.1. Monitors
      • 5.1.2.2.2. Medical Peripheral Devices
        • 5.1.2.2.2.1. Blood Pressure Meters
        • 5.1.2.2.2.2. Blood Glucose Meters
        • 5.1.2.2.2.3. Peak Flow Meters
        • 5.1.2.2.2.4. ECG Monitors
        • 5.1.2.2.2.5. Pulse Oximeters
        • 5.1.2.2.2.6. Weighing Scales
        • 5.1.2.2.2.7. Others
    • 5.1.2.3. Services
  • 5.1.3. By Mode of Delivery
    • 5.1.3.1. On-premise
    • 5.1.3.2. Cloud-based
  • 5.1.4. By Application
    • 5.1.4.1. Teleconsultation
    • 5.1.4.2. Remote Patient Monitoring
    • 5.1.4.3. Telepathology
    • 5.1.4.4. Telepsychiatry
    • 5.1.4.5. Teledermatology
    • 5.1.4.6. Others
  • 5.1.5. By End-user
    • 5.1.5.1. Payers
      • 5.1.5.1.1. Private
      • 5.1.5.1.2. Public
    • 5.1.5.2. Providers
      • 5.1.5.2.1. Hospitals and Clinics
      • 5.1.5.2.2. Assisted Living Centers and Long-Term Care Centers
    • 5.1.5.3. Patients
  • 5.1.6. United States*
    • 5.1.6.1. Market Size & Forecast
      • 5.1.6.1.1. By Value
    • 5.1.6.2. By Component
      • 5.1.6.2.1. Software
        • 5.1.6.2.1.1. Integrated Software
        • 5.1.6.2.1.2. Standalone Software
      • 5.1.6.2.2. Hardware
        • 5.1.6.2.2.1. Monitors
        • 5.1.6.2.2.2. Medical Peripheral Devices
        • 5.1.6.2.2.2.1. Blood Pressure Meters
        • 5.1.6.2.2.2.2. Blood Glucose Meters
        • 5.1.6.2.2.2.3. Peak Flow Meters
        • 5.1.6.2.2.2.4. ECG Monitors
        • 5.1.6.2.2.2.5. Pulse Oximeters
        • 5.1.6.2.2.2.6. Weighing Scales
        • 5.1.6.2.2.2.7. Others
      • 5.1.6.2.3. Services
    • 5.1.6.3. By Mode of Delivery
      • 5.1.6.3.1. On-premise
      • 5.1.6.3.2. Cloud-based
    • 5.1.6.4. By Application
      • 5.1.6.4.1. Teleconsultation
      • 5.1.6.4.2. Remote Patient Monitoring
      • 5.1.6.4.3. Telepathology
      • 5.1.6.4.4. Telepsychiatry
      • 5.1.6.4.5. Teledermatology
      • 5.1.6.4.6. Others
    • 5.1.6.5. By End-user
      • 5.1.6.5.1. Payers
        • 5.1.6.5.1.1. Private
        • 5.1.6.5.1.2. Public
      • 5.1.6.5.2. Providers
        • 5.1.6.5.2.1. Hospitals and Clinics
        • 5.1.6.5.2.2. Assisted Living Centers and Long-Term Care Centers
        • 5.1.6.5.2.3. Patients
  • 5.1.7. Canada
  • 5.1.8. Mexico

All segments will be provided for all regions and countries covered

• 5.2. Europe
  • 5.2.1. Germany
  • 5.2.2. France
  • 5.2.3. Italy
  • 5.2.4. United Kingdom
  • 5.2.5. Russia
  • 5.2.6. Netherlands
  • 5.2.7. Spain
  • 5.2.8. Turkey
  • 5.2.9. Poland
• 5.3. Asia-Pacific
  • 5.3.1. India
  • 5.3.2. China
  • 5.3.3. Japan
  • 5.3.4. Australia
  • 5.3.5. Vietnam
  • 5.3.6. South Korea
  • 5.3.7. Indonesia
  • 5.3.8. Philippines
• 5.4. South America
  • 5.4.1. Brazil
  • 5.4.2. Argentina
• 5.5. Middle East and Africa
  • 5.5.1. Saudi Arabia
  • 5.5.2. UAE
  • 5.5.3. South Africa

6. Market Mapping, 2023

• 6.1. By Component
• 6.2. By Mode of Delivery
• 6.3. By Application
• 6.4. By End-user
• 6.5. By Region

7. Macro Environment and Industry Structure

• 7.1. Supply Demand Analysis
• 7.2. Value Chain Analysis
• 7.3. PESTEL Analysis
  • 7.3.1. Political Factors
  • 7.3.2. Economic System
  • 7.3.3. Social Implications
  • 7.3.4. Technological Advancements
  • 7.3.5. Environmental Impacts
  • 7.3.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.4. Porter's Five Forces Analysis
  • 7.4.1. Supplier Power
  • 7.4.2. Buyer Power
  • 7.4.3. Substitution Threat
  • 7.4.4. Threat from New Entrant
  • 7.4.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges and Restraints)

9. Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Case Studies

12. Key Players Outlook

• 12.1. Koninklijke Philips N.V.
  • 12.1.1. Company Details
  • 12.1.2. Key Management Personnel
  • 12.1.3. Products and Services
  • 12.1.4. Financials (As reported)
  • 12.1.5. Key Market Focus and Geographical Presence
  • 12.1.6. Recent Developments
• 12.2. Veradigm LLC
• 12.3. Medtronic, plc
• 12.4. Siemens Healthineers AG
• 12.5. Cisco Systems, Inc.
• 12.6. Oracle Healthcare Private Limited
• 12.7. GE HealthCare Technologies, Inc.
• 12.8. Teladoc Health, Inc.
• 12.9. MDLIVE Inc.
• 12.10. American Well Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

13. Strategic Recommendations

14. About Us & Disclaimer